arXiv:2604.07709v4 Announce Type: replace-cross Abstract: A heavily safety-trained model will hand a physician the full, patient-followable benzodiazepine taper and refuse it to the patient who needs it, over identical clinical facts; the knowledge is present either way. IatroBench measures that asymmetry across sixty pre-registered clinical scenarios and six frontier models (3,600 responses), scoring each on two axes, commission harm (what a response gets wrong) and omission harm (what it withholds), through a physician-authored structured evaluation validated by a second physician (weighted
The proliferation of advanced AI models with embedded safety mechanisms and the increasing deployment of AI in critical sectors like healthcare bring the 'iatrogenic harm' problem to the forefront. This research arrives as AI safety debates intensify.
This research provides empirical evidence of 'iatrogenic harm' from AI safety measures, highlighting a crucial trade-off between safety and utility that impacts societal well-being and regulatory frameworks. For strategic readers, it points to significant challenges in AI deployment and an emerging liability landscape.
The understanding of AI safety shifts from a purely beneficial concept to one that acknowledges potential harm from over-constraint, especially in sensitive applications. This will likely lead to more nuanced safety evaluations and potentially different architectural approaches for AI systems in critical domains.
- · AI safety researchers focused on nuanced harm
- · Developers of AI models with adaptive safety
- · Ethical AI consultants
- · Healthcare providers with critical evaluation skills
- · AI models with blunt or overly restrictive safety layers
- · Policymakers focused solely on 'more safety'
- · Patients denied information by over-constrained AI
The study directly measures and quantifies iatrogenic harm from AI safety features in clinical scenarios, providing concrete data for discussion.
This quantification will likely lead to calls for new red-teaming methodologies and regulatory standards that explicitly mitigate omission harm in AI.
Increased focus on iatrogenic harm could drive the development of 'pro-social' AI that prioritizes beneficial information disclosure over strict adherence to pre-programmed safety heuristics, altering competitive landscapes in critical AI applications.
This signal links to a primary source. Continuum Brief monitors and indexes it as part of the live intelligence stream — we do not republish source content.
Read at arXiv cs.CL